Lynx Investment Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $370K | Buy |
1,993
+23
| +1% | +$4.27K | 0.24% | 92 |
|
|
2025
Q1 | $413K | Buy |
1,970
+11
| +0.6% | +$2.31K | 0.28% | 80 |
|
|
2024
Q4 | $348K | Buy |
1,959
+248
| +14% | +$44.1K | 0.24% | 95 |
|
|
2024
Q3 | $338K | Buy |
1,711
+101
| +6% | +$19.9K | 0.24% | 91 |
|
|
2024
Q2 | $276K | Buy |
+1,610
| New | +$276K | 0.2% | 105 |
|